Case Study: Professional Services Firm gains cell and gene therapy go-to-market insights with GLG Surveys

How will Pharmacy Business Units Bring New Drugs to Market

Professional Services Firm partnered with GLG to better understand how pharmaceutical companies manage cell and gene therapy drugs. The project team needed senior pharma perspectives on how these therapies would be priced and brought to market, and they used GLG Surveys to gather those insights.

GLG designed and ran a B2B survey of 42 executives overseeing pharmacy business units for payors, including VPs at pharma companies and other pharmacy and healthcare payment experts. The results helped the Professional Services Firm understand go-to-market strategies and utilization forecasting for cell and gene therapy drugs, enabling the team to better advise its client.